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Background: Acetylcholine (ACh) is known to be a key neurotransmitter in the central and peripheral nervous
systems, which is also produced in a variety of non-neuronal tissues and cell. The existence of ACh in maxilla in vivo
and potential regulation role for osteogenesis need further study.
Results: Components of the cholinergic system (ACh, esterase, choline acetyltransferase, high-affinity choline
uptake, n- and mAChRs) were determined in maxilla of rat in vivo, by means of Real-Time PCR and immunohistochemistry.
Results showed RNA for CarAT, carnitine/acylcarnitine translocase member 20 (Slc25a20), VAChT, OCTN2, OCT1, OCT3,
organic cation transporter member 4 (Slc22a4), AChE, BChE, nAChR subunits α1, α2, α3, α5, α7, α10, β1, β2, β4, γ and
mAChR subunits M1, M2, M3, M4, M5 were detected in rat’s maxilla. RNA of VAChT, AChE, nAChR subunits α2, β1, β4 and
mAChR subunits M4 had abundant expression (2-ΔCt > 0.03). Immunohistochemical staining was conducted for ACh,
VAChT, nAChRα7 and AChE. ACh was expressed in mesenchymal cells, chondroblast, bone and cartilage matrix and bone
marrow cells, The VAChT expression was very extensively while ACh receptor α7 was strongly expressed in newly formed
bone matrix of endochondral and bone marrow ossification, AchE was found only in mesenchymal stem cells, cartilage
and bone marrow cells.
Conclusions: ACh might exert its effect on the endochondral and bone marrow ossification, and bone matrix
mineralization in maxilla.
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Acetylcholine (Ach) acting solely as neurotransmitter
has been revised by findings published both early and
late in the last century which all demonstrated the exist-
ence of Ach in non-neuronal systems [1,2]. Cholinergic
communication and regulation are established from the
beginning of life, that is, in primitive uni- and multicel-
lular organisms such as bacteria, algae, protozoa, sponge
and primitive plants and fungi [3-5].
Increasing evidence indicates that ACh acts as an
paracrine and autocrine signaling molecule which con-
trolling basic cell functions, such as proliferation, dif fer-
entiation, cell–cell contact, immune functions, secretion,
and absorption in non-neuronal cell including epithelial,
endothelial, mesothelial, immunocompetent, and smooth* Correspondence: xiaoxiache77@163.com
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unless otherwise stated.muscle cells [2,6,7]. Non-neuronal cells possess choliner-
gic components uptake choline by means of the high affin-
ity choline transporter (CHT1) [8], and then synthesize
ACh by choline acetyltransferase (ChAT) [9] from choline
and acetyl-coenzyme A (acetyl-CoA).
ACh is translocated into small synaptic vesicles by ves-
icular ACh transporter (VAChT), and released via exocyt-
osis [10]. Once released, ACh exerts its cellular functions
via nicotinic acetylcholine receptors (nAChRs), including
16 subunits (α1, α2, α3, α4, α5, α6, α7, α9, α10, β1, β2, β3,
β4, γ, δ and ε) and muscarinic acetylcholine receptor
(mAChRs), which including 5 subtypes (M1, M2, M3, M4
and M5). Finally, ACh is rapidly degraded into choline and
acetate by acetylcholinesterase and butyrylcholinesterase
(AChE and BChE) [11].
As described in the non-neuronal cholinergic systems
of other cell types and tissues, the presence of all the ne-
cessary molecular components of ACh synthesis, release,
reception, degradation, and reuptake existed in mouse
and human osteoblast-like cells [12]. Osteoblasts expressis is an Open Access article distributed under the terms of the Creative
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nents, and ACh plays a potential role in regulating the pro-
liferation and differentiation of osteoblasts [13]. nAChRs
include the α2 nAChRs subunit have a key role in regulat-
ing skeletal remodeling mainly through an inhibitory tone
of bone resorption [14]. However, whether Ach existed in
bone in vivo is still undetermined. In this study, we studied
the existence of ACh in maxilla in vivo and their potential
regulation role for osteogenesis.
Results and discussion
The morphology of maxilla
Essentially, mammalian bones are in the form of 2 differ-
ent ways: long bones via endochondral ossification; and
flat bones via intramembranous ossification. Orofacial
bone is mainly formed via intramembranous ossification
[15,16]. These bony types show considerable differences
in protein composition [17]. The morphology of maxilla
harvested in this study showed in Figure 1A. A complete
palatal shelf structure in a normal SD rat is shown in
Figure 1B. The bony plates were interposed between
two layers of soft tissue, the nasal and oral mucosa. The
palatine vessels and nerves formed large bundles and
were housed in bilateral concavities in the bone, and a
single layer of osteoblasts lined the oral and nasal
surfaces of the bone.
Real-Time PCR analysis of the components of
non-neuronal cholinergic system in maxilla
We screened RNA for the expression of all non-neuronal
cholinergic system components, including esterase, cho-
line acetyltransferase, high-affinity choline uptake, organic
cation transporters, carnitine/acylcarnitine translocase,
n- and mAChRs. Result showed CHT1, ChAT, OCT2,
SLC25a29 and nAChR subunits α4, α6, α9, β3, δ, ε were
not detected in maxilla. While the RNA of AChE, BChE,
CarAT, carnitine/acylcarnitine translocase member 20
(Slc25a20), VAChT, OCTN2, OCT1, OCT3, organic cationFigure 1 Maxilla from a normal SD rat: A, Maxilla specimen for PCR atransporter member 4 (Slc22a4), nAChR subunits α1, α2,
α3, α5, α7, α10, β1,β2, β4, γ and mAChR subunits M1,
M2, M3, M4, M5 were detected in rat’s maxilla.
The RNA of VAChT, AChE, nAChR subunits α2, β1,
β4 and mAChR subunits M4 had abundant expression
(2-ΔCt > 0.03) (Figure 2). And RNA of CarAT, OCT1,
nAChR subunits α1, α5, α7, α10, mAChR subunits M2, M3
had less abundant expression(0.005 ≤ 2-ΔCt ≤ 0.03), and the
other components had low expression level (2-ΔCt < 0.005).
Immunohistochemistry of ACh, VAChT, nAChRα7 and
AChE in maxilla
Traditional methods for the detection of acetylcholine
were high performance liquid chromatography (HPLC)
and micro dialysis, but location of acetylcholine could
not be determined by these methods. Antibodies of
choline-protein conjugates introduced by Lolin et al.
provided a potentially method to detect ACh [18]. Later
Schlereth et al. found conjugated ACh–glutaryl-BSA
(bovine serum albumin) the most immunoreactive immu-
nogen by the injection of different ACh- conjugates into
AKR and DBA mice followed by ELISA detection for the
affinity and specificity of immune serum [19]. The immu-
nogen of anti-acetylcholine polyclonal antibody used for
our immunohistochemistry was also acetylcholine-glutaric
anhydride- poly lysine.
Figure 3 demonstrated the immunohistochemistry re-
sults. As we can see, ACh was expressed in mesenchymal
stem cells, chondroblast, bone and cartilage matrix and
bone marrow cells (Figure 3A), this indicates that the max-
illa also expressed non-neuronal acetylcholine. The immu-
nohistochemistry results of negative control and positive
control of ACh antibodies can be found in Additional file 1:
Figure S1. The VAChT was expressed very extensively, but
less intense (Figure 3B), which showed that ACh was trans-
ported to many parts of the maxilla, and played a part in
bone metabolism. As ACh receptor, α7 are strongly
expressed in newly formed bone matrix of endochondralnalysis; B, The palatal shelf structure of maxilla.
Figure 2 Gene expression of the non-neuronal cholinergic system: A, The expression of synthesis transport and degradation systems,
including CarAT, OCTN2, OCT1, OCT3, SLC22a4, SLC25a20, VAChT, AChE, BChE; B, The expression of nAChR subunits, including α1, α2,
α3, α5, α7, α10, β1,β2, β4 and γ; C, The expression of mAChR subunits, including M1, M2, M3, M4 and M5.
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that ACh must be involved in the formation of bone
matrix. The AChE, degrading of acetylcholine, had a nar-
row distribution, only in mesenchymal stem cells, cartilage
and bone marrow cells (Figure 3D), which indicats that
ACh might contribute to the metabolism in the maxillary
bone of normal rats.
ACh was synthesized by practically all living cells and
can play an intermediary role in the interactions of non-neuronal cells with the external environment, hormones,
growth factors, cytokines and also the neural system
[20-23]. Immunohistochemical staining of trabecular bone
in the distal femoral metaphysis demonstrated VAChT
positive regional in medullary intertrabecular spaces,
mainly in the close vicinity of bony struts, one-to-three
cell layers away from their surface [14]. The alpha-7 nico-
tinic acetylcholine receptor (α7-nAChR) was well known
as a potent calcium ionophore. Rogers et al. described the
Figure 3 Immunohistochemical results of ACh, VAChT, α7 and AChE in maxilla cells: A, ACh was expressed in mesenchymal stem cells,
chondroblast, bone and cartilage matrix and bone marrow cells; B, VAChT was expressed in mesenchymal stem cells, chondroblast
and cartilage; C, nAChRα7 was expressed in bone matrix of endochondral and bone marrow ossification, and bone marrow cells;
D, AChE was expressed in mesenchymal stem cells, cartilage and bone marrow cells.
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show that for this nicotinic receptor the distinct spatial
and temporal differences in its expression suggested func-
tional pleiotropy in the tooth developmental process [24].
AChE had been detected as nuclear protein in both
neuronal and non-neuronal cells [25]. The chondrogenic
expression of AChE paralleled the early development of
rat lower limbs [26]. AChE fulfilled at least some of the
requirements for an osteogenic coordinator.
In maxilla ACh might be produced by carnitine acetyl-
transferase (CarAT), not choline acetyltransferease (ChAT),
which was consistent with some non-neuronal cells such
as muscle cells and urothelial epithelial cells [9,27]. Bajayo
et al. [14] demonstrated that VAChT had been expressed
in trabecular bone in the distal femoral metaphysic when
compared the expression of VAChT mRNA with OCTs’,
this indicated that bone transport ACh by VAChT. They
also find AChE expressed extremely rich, whereas BChE
expressed very little, this illustrated that ACh was degraded
mainly by AChE in maxilla.
Sato et al. showed that Nic, an agonist of nAChRs,
induced proliferation of osteoblasts [28]. It was demon-
strated previously that osteoblasts mainly expressing the
muscular type α1, β1, and γ subunits, as well as the neur-
onal subunits α4, α7, β2, and β4 [14]. But our Real-Time
PCR result indicated that many components of nAChRs
existed in maxilla, especially the subunits α1, α2, α10, β1
and β4. On the other hand, the ingredients of mAChRsexpressed largely, except M1 subunit. Kliemann et al. [29]
indicated a significant decrease in relative bone volume,
trabecular thickness, trabecular number, bone surface
density, and a significant increase in trabecular separation
and structure model index of M3R–KO using Micro-CT
analysis. All these show that non-neuronal cholinergic
system involved in bone formation.
We hypothesized that ACh plays a functional role in
bone metabolism. ACh increased the viability, but de-
creased the proliferation of embryonic stem cells [30].
ACh was expressed in mesenchymal cells, chondroblast,
bone and cartilage matrix and bone marrow cells, so we
suppose that ACh might participate in the metabolism
of the maxilla. ACh had abundant expression in mesen-
chymal cells, chondroblast and cartilage matrix, this
illustrating that ACh might be related with membrane
bone and cartilage mineralization. In addition, ACh has
been expressed in bone matrix and bone marrow cells,
so, we hypothesized that acetylcholine had relevant to
bone marrow ossification.
ACh, VAChT, nAChR α7 and AChE are expressed in
bone marrow mesenchymal stem cells; ACh might
participate in the proliferation, differentiation and death
of bone marrow stem cells. ACh, VAChT and nAChR α7
are expressed in bone matrix of endochondral and bone
marrow ossification, but AChE is not expressed, further
illustrated that the non-neuronal cholinergic system par-
ticipated in osteogenesis and bone matrix mineralization.
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and cartilage cells, indicating that the system were con-
cerned with the cartilage cells formation, and might be
involved in cartilage ossification.Conclusions
The non-neuronal cholinergic system is expressed in the
maxilla. ACh mainly transported by VAChT, degraded
by AChE, and came into play by parts of nAChR and
mAChR subunits, major α1, α2, α10, β1, β4 and M2,
M3, M4, M5. The immunohistochemistry of 4 constitu-
ents (ACh, VAChT, nAChRα7 and AChE) indicating that
non-neuronal cholinergic system participated in the
proliferation, differentiation and death of mesenchymal
stem cells, cartilage and bone marrow cells, worked in
the endochondral and bone marrow ossification, andTable 1 Sequences and accession numbers for forward and re




























18S M11188 GCGGTTCTbone matrix mineralization as well. However, the role of
non-neuronal cholinergic system still need be further
researched.Methods
Animals and ethics statement
All of the rats were treated according to the ethical regula-
tions defined by the Ethics Committee of Capital Medical
University.
Male Sprague–Dawley rats purchased from Research
Institute of Drug Inspection of China (n = 9, 7–8 week-
old, mean weight of 302.14 ± 8.42 g). All rat were decapi-
tated under anesthesia on 7th day, and the maxilla was
harvested (Figure 1A). Specimens from 6 rats were used
for Real-Time PCR analysis and specimens from the other
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non-neuronal cholinergic system in maxilla
Real-Time PCR analysis was performed with a Roche 480
Sequence Detection System according to manufacturer’s
instructions (ROCHE GROUP, Basel, Switzerland) for
validation of gene expression of the cholinergic system.
The maxilla from the first to the third molars in rats
were harvested free of the overlying soft tissue. Speci-
mens were ground under liquid nitrogen, and then
mixed with Trizol solution (Invitrogen, Carlsbad, CA,
USA). RNA was treated with DNase I (TAKARA, DA-
LIAN) to eliminate genomic DNA. The yield and purity
of RNA was estimated spectrophotometrically using the
A260/A280 ratio and agarose gel electrophoresis. RNA
was reverse transcribed to cDNA using the superscript
III reverse transcriptase (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions.
The cDNAs were amplified with gene-specific primer
pairs (listed in Table 1). Reactions were run on the
Roche 480 Real-Time PCR detection system and the re-
sults were analyzed using the software supplied with the
machine. The running conditions were: incubated at 50°C
for 2 minutes and 95°C for 5 minutes, followed by 45 cy-
cles of incubation at 95°C for 15 s and 60°C for 1 minute.
The β-actin of rat and 18S gene was used as 2 internal
controls. The expression levels of the target genes were
correlated to mean of β-actin and 18 s using the 2-ΔCt
method.
Hematoxylin and eosin staining of maxilla
The palates from the first to third molars of rats were fixed
in 10% formalin solution for 48 h. The blocked tissues were
demineralized in 10% (w/v) ethylenediaminetetra-acetic
acid (EDTA) for 14 days at 4°C. Routine paraffin embed-
ding procedures were performed. Sections (5 μm thick)
were cut and mounted on poly-L-lysine–coated glass slides.
Before staining, sections were incubated at 60°C for 1 h and
then held in xylene and rehydrated through a series of etha-
nol solutions. Sections were stained with hematoxylin and
eosin to observe the histological morphology. The staining
imaging was captured using an OLYMPUS BX61 (Tokyo,
Japan) optical microscope.
Immunohistochemistry of Ach, VAChT, nAChR α7
and AChE
Prepared sections were reacted with anti-ACh (Chemi-
con), anti-VAChT (Abcam), anti-α7 nAChR (Abcam)
and anti-AChE (Novus) antibodies. An immunohisto-
chemical staining secondary antibodies kit (Maixin Bio-
technology, Inc., Fuzhou China) was used according to
the manufacturer’s instructions, and then colored with
DAB (Maixin Biotechnology, Inc., Fuzhou China). Sec-
tions were counterstained with hematoxylin before they
were covered. Immunohistochemical staining imagingwas captured using an OLYMPUS BX61 (Tokyo, Japan)
optical microscope.
Statistical analysis
Data were expressed as mean ± standard deviation. The
data was subjected to ANOVA analysis. P < 0.05 were
considered as significant. Statistical analyses were per-
formed using the SPSS 17.0 software.Additional file
Additional file 1: Figure S1. Negative control and positive control
of ACh antibodies.
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